GB0822625D0 - In vitro protein expression process comprising Ck fusion molecules - Google Patents

In vitro protein expression process comprising Ck fusion molecules

Info

Publication number
GB0822625D0
GB0822625D0 GBGB0822625.0A GB0822625A GB0822625D0 GB 0822625 D0 GB0822625 D0 GB 0822625D0 GB 0822625 A GB0822625 A GB 0822625A GB 0822625 D0 GB0822625 D0 GB 0822625D0
Authority
GB
United Kingdom
Prior art keywords
protein expression
fusion molecules
vitro protein
expression process
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0822625.0A
Other versions
GB2452201A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Babraham Institute
Original Assignee
Babraham Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babraham Institute filed Critical Babraham Institute
Publication of GB0822625D0 publication Critical patent/GB0822625D0/en
Publication of GB2452201A publication Critical patent/GB2452201A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
GB0822625A 2006-06-21 2007-06-21 In vitro protein expression process comprising Ck fusion molecules Withdrawn GB2452201A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0612223A GB0612223D0 (en) 2006-06-21 2006-06-21 Ck fusion molecules
PCT/GB2007/002309 WO2007148092A2 (en) 2006-06-21 2007-06-21 In vitro protein expression process comprising cκ fusion molecules

Publications (2)

Publication Number Publication Date
GB0822625D0 true GB0822625D0 (en) 2009-01-21
GB2452201A GB2452201A (en) 2009-02-25

Family

ID=36803566

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0612223A Ceased GB0612223D0 (en) 2006-06-21 2006-06-21 Ck fusion molecules
GB0822625A Withdrawn GB2452201A (en) 2006-06-21 2007-06-21 In vitro protein expression process comprising Ck fusion molecules

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0612223A Ceased GB0612223D0 (en) 2006-06-21 2006-06-21 Ck fusion molecules

Country Status (3)

Country Link
EP (1) EP2029764A2 (en)
GB (2) GB0612223D0 (en)
WO (1) WO2007148092A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9937239B2 (en) 2014-05-21 2018-04-10 The Johns Hopkins University Preservation and reconstitution of cell-free protein expression systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2063035A1 (en) * 1991-03-27 1992-09-28 Klaus Karjalainen Chimaeric antibodies containing the ligand domain of cd4
EP1732946B1 (en) * 2004-03-08 2011-07-27 ZymoGenetics, Inc. Dimeric fusion proteins and materials and methods for producing them

Also Published As

Publication number Publication date
WO2007148092A8 (en) 2009-07-16
GB0612223D0 (en) 2006-08-02
WO2007148092A3 (en) 2008-02-07
GB2452201A (en) 2009-02-25
WO2007148092A2 (en) 2007-12-27
EP2029764A2 (en) 2009-03-04

Similar Documents

Publication Publication Date Title
IL196674A0 (en) Exendin fusion proteins
IL196889A0 (en) Albumin-insulin fusion proteins
ZA200810677B (en) Fusion proteins, uses thereof and processes for producing same
EP2173377A4 (en) Antibody-endostatin fusion protein and its variants
EP1858546A4 (en) Modified transferrin fusion proteins
IL222924A0 (en) Albumin fusion proteins
HK1120273A1 (en) Anti-fgf19 antibodies and methods using same fgf19
IL197580A0 (en) Albumin fusion proteins
PL2007884T3 (en) Cellulase fusion proteins and their use
ZA200908649B (en) Rage fusion proteins
EP2161287A4 (en) OPTIMIZED TACI-Fc FUSION PROTEINS
IL195839A0 (en) New protein conjugates and methods for their preparation
ZA200900494B (en) DNA Molecules and methods
ZA200904757B (en) Transferrin fusion protein libraries
EP1931379A4 (en) Proteins with improved solubility and methods for producing and using same
GB0822625D0 (en) In vitro protein expression process comprising Ck fusion molecules
EP2006302A4 (en) Protein complex and process for production thereof
IL206334A0 (en) Sarp-i fusion proteins and their use
EP2034013A4 (en) Process for the production of bromelain by means of substances that induce proteins in pineapple plants
ZA200808656B (en) Enzyme fusion proteins and their use
GB0700759D0 (en) Novel fusion protein
ZA200900014B (en) Optimisation in rotomoulded applications
GB0601743D0 (en) Process and products for protein expression
GB0715325D0 (en) Fertilisation protein
GB0713169D0 (en) Fusion proteins

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)